Dopaminergic System and Addiction
Keywords:
Addiction, dopamine, genetic, neurobiologyAbstract
Dopamine is a common neurotransmitter in central nervous system. Researchers were reporting that dopamine plays an important role in the development and persistence of addiction. Most important contribution revealing the association of dopaminergic system with addiction comes from brain imaging studies and pharmacological researches. These studies were mentioning that dopaminergic system was involved in the development and persistence of addiction by effecting brain reward system, craving and cognitive processes. Association of dopaminergic system and addiction was also investigated by genetic and epigenetic studies. In this paper we aimed to review the association of dopaminergic system with addiction.
References
Uzbay İT. Nöropsikofarmakoloji, Rasyonel İlaç Kullanımı. Yorum Yayıncılık& İstanbul Tıp Kitabevi 2007,-147-155.
Koob GF. The neurobiology of addiction: a neuroadaptatîonal view relevant for diagnosis. Addiction. 2006,101 (Suppl 1):23-30.
Di Chiara G, Bassareo V. Reward system and addiction: what dopamine does and doesn't do. Curr Opin Pharmacol. 2007;7:69-76.
Franken IH, Booij J, van den Brink W. The role of dopamine in human addiction: from reward to motivated attention. Eur J Pharmacol. 2005;526:199-206.
Kalivas PW. Recent understanding in the mechanisms of addiction. Curr. Psychiatry Rep. 2004;6:347-351
Köhnke MD. Approach to the genetics of alcoholism: a review based on pathophysiology. Biochem Pharmacol. 2008;75:160-177.
Renthal W, Nesiler EJ. Epigenetic mechanisms in drug addiction. Trends mol med. 2008;14:341-3 50.
Uzbay IT. Madde Bağımlılığı ve Dopaminerjik Sistem. Türkiye Klinikleri Dahili Tıp Bilimleri Dergisi Psikiyatri 2005;47:65-72
Wise RA, Bozarth MA. A psychomotor stimulant theory of addiction. Psychol. Rev. 1987;94:469-492.
Barrett SP, Boileau I, Okker J, et al. The hedonic response to cigarette smoking is proportional to dopamine release in the human striatum as measured by positron emission tomography and [(11)0 raclopride. Synapse 2004;54;65-71.
Volkow ND, Fowler JS, Wang GJ, et al. Dopamine in drug abuse and addiction: results of imaging studies and treatment implications. Arch Neurol. 2007;64:1575-9.
Oswald EM, Wong DF, McCaul M, et al. Relationships among ventral striatal dopamine release, cortisol secretion, and subjective responses to amphetamine. Neuropsychopharmacology 2005;30, 821-832.
Volkow ND, Wang GJ, Fowler JS, et al. Brain DA D2 receptors predict reinforcing effects of stimulants in humans: replication study. Synapse. 2002;46:79-82.
Sienkiewicz-Jarosz H, Scinska A, Kuran W, et al. Taste responses in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 2005;76:40-46.
Brauer LH, De Wit H. High dose pimozide does not block amphetamine-induced euphoria in normal volunteers. Pharmacol Biochem Behav 1997;56:265-272
Leyton M, Casey KF, Delaney JS, et al. Cocaine craving, euphoria, and selfadministration: a preliminary study of the effect of catecholamine precursor depletion. Behav Neurosci 2005; 119:1619-1627
Berridge KC. The debate over dopamine's role in reward: the case for incentive salience. Psychopharmacology (Berl). 2007;191:391-431.
Volkow ND, Fowler JS, Wang GJ. The addicted human brain: insights from imaging studies. J. Clin. Invest. 2003;! 11,1444-1451.
Nestler EJ. Molecular mechanisms of drug addiction. Neuropharmacology 2004;47:24-32.
Robinson TE, Berridge KC. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Rev. 1993,18, 247-291.
Yasuno F, Ota M, Ando K, et al. Role of ventral striatal dopamine D1 receptor in cigarette craving. Biol Psychiatry. 2007;61:1252-9.
Zijlstra F, Booij J, van den Brink W, et al. Striatal dopamine D2 receptor binding and dopamine release during cue-elicited craving in recently abstinent opiate-dependent males. Eur Neuropsychopharmacol. 2008;18:262-70.
Soares BG, Lima MS, Reisser AA, et al. Dopamine agonists for cocaine dependence. Cochrane Database Syst Rev. 2003;2:1-45.
Soyka M, De Vry J. Flupenthixol as a potential pharmacotreatment of alcohol and cocaine abuse/dependence. Eur Neuropsychopharmacol. 2000; 10:325-32.
Amato L, Minozzi S, Pani PP, et al. Antipsychotic medications for cocaine dependence. Cochrane Database Syst Rev. 2007; 18:1-28.
Martinotti G, DI Nicola M, Di Giannantonio M, et al. Aripiprazole in the treatment of patients with alcoholdependence:adouble-blind, comparison trial vs. Naltrexone. J Psychopharmacol. 2008 doi: 10.1177/0269881108089596.
Franken IH, Stam CJ, Hendriks VM, et al. Neurophysiological evidence for abnormal cognitive processing of drug cues in heroin dependence. Psychopharmacology 2003;170,205-212.
Franken IH, Hendriks VM, Stam CJ, et al. A role for dopamine in the processing of drug cues in heroin dependent patients. Eur. Neuropsychopharmacol. 2004;14, 503-508.
Marissen MA, Franken IH, Waters AJ, et al Attentionalblaspredictsheroin relapse following treatment. Addiction. 2006;101:1306-12.
Blum K, Sheridan PJ, Wood RC, et al. The D2 dopamine receptor gene as a determinant of reward deficiency syndrome. J R Soc Med. 1996;89:396-400.
Smith L, Watson M, Gates S, et al. MetaAnalysis of the Association of the Taq1A Polymorphism with the Risk of Alcohol Dependency: A HuGE Gene-Disease Association Review. Am J Epidemiol 2008;167:125-138
Shahmoradgoli Najafabadi M, Ohadi M, et al. Association between the DRD2 A1 allele and opium addiction in the Iranian population. Am J Med Genet B Neuropsychiatr Genet. 2005;1346:39-41.
Erblich J, Lerman C, Self DW, et al. Stress-induced cigarette craving: effects of the DRD2 Taql RFLP and SLC6A3 VNTR polymorphisms. Pharmacogenomics J. 2004;4:102-9.
Haile CN, Kosten TR, Kosten TA. Genetics of dopamine and its contribution to cocaine addiction. Behav Genet. 2007;37:119-45.
Shao C, Li Y, Jiang K, et al. Dopamine D4 receptor polymorphism modulates cue-elicited heroin craving in Chinese. Psychopharmacology (Berl). 2006;186:185-90.
Franklin TR, Lohoff FW, Wang Z, et al. DAT genotype modulates brain and behavioral responses elicited by cigarette cues. Neuropsychopharmacology. 2009,34:717-28.
Schmidt LG, Harms H, Kuhn S, et al. Modification of alcohol withdrawal by the A9 allele of the dopamine transporter gene. Am J Psychiatry 1998; 155:474-478.
Kreek MJ, Bart G, Lilly C, et al. Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments. Pharmacol Rev. 2005;57:1-26.
UJike H, Harano M, Inada T, et al. Nine- or fewer repeat alleles in VNTR polymorphism of the dopamine transporter gene is a strong risk factor for prolonged methamphetamine psychosis. Pharmacogenomics J. 2003;3:242-247.
Gelernter J, Kranzler HR, Satel SL, et al. Genetic association between dopamine transporter protein alleles and cocaine-induced paranoia. Neuropsychopharmacology. 1994; 11:195-200
Lott DC, Kim SJ, Cook EH, et al. Dopamine transporter gene associated with diminished subjective response to amphetamine. Neuropsychopharmacology 2005;30:602-9.
Zalsman G, Huang YY, Harkavy-Friedman JM, et al. Relationship of MAO-A promoter (u- VNTR) and COMT (V158M) gene polymorphisms to CSF monoamine metabolites levels in a psychiatric sample of Caucasians: a preliminary report. Am J Med Genet B Neuropsychiatr Genet 2005;132:100-3.
Guindalini C, Laranjeira R, Collier D, et al. Dopamine-beta hydroxylase polymorphism and cocaine addiction. Behav Brain Fund. 2008;4:1 -4.
Lohoff FW, Weller AE, Bloch PJ, et al. Association between the catechol-O-methyltransferase Val158Met polymorphism and cocaine dependence. Neuropsychopharmacology. 2008;33:3078-84.
Ito H, Hamajima N, Matsuo K, et al. Monoamine oxidase polymorphisms and smoking behaviour in Japanese. Pharmacogenetics. 2003;13:73-9.
Tsankova N, Renthal W, Kumar A, et al. Epigenetic regulation in psychiatric disorders. Nat Rev Neurosci 2007; 8:355-367.
Nestler EJ. The neurobiology of cocaine addiction. Sci Pract Perspect. 2005 Dec;3:4-10.
Hillemacher T, Fueling H, Hartl T, et al. Promoter specific methylation of the dopamine transporter gene is altered in alcohol dependence and associated with craving. J Psychiatr Res. 2009;43:388-92.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Journal of Dependence
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
...